LI-RADS v2018: a Primer and Update for Clinicians

AbstractPurpose of ReviewTo familiarize readers with recent updates and additions to the Liver Imaging and Reporting Data System (LI-RADS) v2018 for hepatocellular carcinoma surveillance, diagnosis, and treatment response assessment.Recent FindingsUS surveillance, diagnosis, and treatment response assessment algorithms are now incorporated into LI-RADS v2018. Updates to the diagnostic algorithm for CT and MRI include clarification of the LI-RADS appropriate population, revision of LR-5 criteria to match with those advocated by the American Association for Study of Liver Disease, new specific criteria for the LR-M category, and modification of the tumor in vein (TIV) category.SummaryLI-RADS v2018 facilitates clear communication between radiologists and the rest of the health care team by standardizing imaging terminology, interpretation, and reporting. LI-RADS also enhances imaging quality by providing minimal technical requirements for hepatocellular carcinoma imaging. Recent updates address US surveillance, clarify terminology, and incorporate treatment response. With these updates, LI-RADS addresses the entire spectrum of hepatocellular carcinoma imaging from screening to treatment response, thereby further promoting its integration into practice.

Source: Current Hepatitis Reports - October 24, 2018 Category: Infectious Diseases Source Type: research